Not Rated
|
Fund Size
(0.59% of Investment in Category)
|
Expense Ratio
(0.88% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 07-Nov-25 | 10047.10 | 0.47% | - | 1.06% | 228/230 |
| 1 Month | 14-Oct-25 | 10288.50 | 2.89% | - | 2.14% | 124/226 |
| 3 Month | 14-Aug-25 | 10067.20 | 0.67% | - | 4.73% | 219/224 |
| 6 Month | 14-May-25 | 10905.30 | 9.05% | - | 8.05% | 93/214 |
| YTD | 31-Dec-24 | 9687.80 | -3.12% | - | 5.51% | 187/201 |
| 1 Year | 14-Nov-24 | 10009.30 | 0.09% | 0.09% | 8.71% | 171/187 |
| 2 Year | 13-Nov-23 | 15155.50 | 51.55% | 23.04% | 20.48% | 46/141 |
| 3 Year | 14-Nov-22 | 18617.20 | 86.17% | 23.00% | 20.32% | 36/117 |
| 5 Year | 13-Nov-20 | 24067.80 | 140.68% | 19.18% | 22.29% | 66/93 |
| Since Inception | 30-Nov-18 | 44186.00 | 341.86% | 23.79% | 14.34% | 22/223 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 14-Nov-24 | 12000 | 12416.93 | 3.47 % | 6.48 % |
| 2 Year | 13-Nov-23 | 24000 | 27177.31 | 13.24 % | 12.42 % |
| 3 Year | 14-Nov-22 | 36000 | 48664.41 | 35.18 % | 20.55 % |
| 5 Year | 13-Nov-20 | 60000 | 96954.68 | 61.59 % | 19.25 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Cipla Ltd. | Pharmaceuticals | 2688.1 | 8.55% | -0.21% | 9.53% (Apr 2025) | 7.86% (Nov 2024) | 17.90 L | 0.00 |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 2596.2 | 8.26% | 0.30% | 10.78% (Mar 2025) | 7.88% (Aug 2025) | 15.36 L | 0.00 |
| Suven Pharmaceuticals Ltd. | Pharmaceuticals | 2235.8 | 7.11% | -0.79% | 10.25% (Feb 2025) | 7.11% (Oct 2025) | 29.68 L | 2.04 L |
| Ipca Laboratories Ltd. | Pharmaceuticals | 2156.4 | 6.86% | -0.53% | 8.16% (Apr 2025) | 6.86% (Oct 2025) | 16.96 L | 0.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 2115.1 | 6.73% | 0.66% | 6.73% (Oct 2025) | 3.39% (Nov 2024) | 22.18 L | 0.00 |
| Gland Pharma Ltd. | Pharmaceuticals | 1775.9 | 5.65% | -0.31% | 5.96% (Sep 2025) | 4.38% (Dec 2024) | 9.21 L | 0.00 |
| ILLUMINA | Foreign equity | 1758.1 | 5.59% | 1.19% | 5.77% (Jan 2025) | 3.61% (Mar 2025) | 1.60 L | 0.00 |
| Sai Life Sciences Ltd. | Petrochemicals | 1645.6 | 5.23% | 0.46% | 5.23% (Oct 2025) | 0% (Nov 2024) | 17.92 L | 89.23 k |
| Apollo Hospitals Enterprises Ltd. | Hospital | 1496 | 4.76% | 0.07% | 4.77% (Aug 2025) | 3.91% (Nov 2024) | 1.95 L | 0.00 |
| Globus Medical Inc | Foreign equity | 1440.2 | 4.58% | 0.13% | 6.75% (Jan 2025) | 3.88% (Jul 2025) | 2.69 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 1.51% |
| MF Units | MF Units | 0.79% |
| Net Receivables | Net Receivables | -0.21% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 421.51 | 2.75 | 14.90 | 45.71 | 45.35 | 37.04 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 273.51 | 0.99 | 2.73 | 14.92 | 29.78 | 15.95 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 680.73 | 4.59 | 10.15 | 19.63 | 27.32 | 0.00 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 297.12 | 1.74 | 8.55 | 17.85 | 24.60 | 13.66 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1733.63 | -0.66 | 10.43 | 19.32 | 24.58 | 0.00 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 333.18 | 3.84 | 9.67 | 9.60 | 24.09 | 15.83 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 9273.44 | 3.03 | 7.61 | 12.01 | 23.52 | 21.10 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1518.73 | 1.60 | 8.54 | 8.13 | 23.39 | 0.00 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7556.72 | 0.54 | 6.08 | 5.62 | 23.22 | 0.00 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 292.35 | 2.30 | 3.80 | 13.49 | 23.18 | 17.98 |
Out of 63 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 8 is/are ranked 4 * , 11 is/are ranked 3 * , and 38 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| DSP Midcap Fund - Direct Plan - Growth | 3 | 19609.01 | 2.10 | 4.67 | 8.61 | 7.99 | 20.65 |
| DSP Liquidity Fund - Direct Plan - Growth | 3 | 19054.79 | 0.50 | 1.47 | 3.05 | 6.76 | 7.08 |
| DSP ELSS Tax Saver Fund - Direct Plan - Growth | 5 | 17241.31 | 3.54 | 5.45 | 5.43 | 9.07 | 20.65 |
| DSP Small Cap Fund - Direct Plan - Growth | 3 | 16867.93 | 3.57 | 4.02 | 10.75 | 5.48 | 21.77 |
| DSP Large & Mid Cap Fund - Direct Plan - Growth | 4 | 16530.07 | 3.40 | 5.59 | 5.70 | 8.92 | 21.19 |
| DSP Flexi Cap Fund - Direct Plan - Growth | 3 | 12197.68 | 3.09 | 5.85 | 5.85 | 7.19 | 18.63 |
| DSP Aggressive Hybrid Fund - Direct Plan - Growth | 4 | 11909.72 | 1.66 | 2.80 | 2.76 | 8.48 | 17.03 |
| DSP Savings Fund - Direct Plan - Growth | 4 | 7524.16 | 0.51 | 1.55 | 3.36 | 7.40 | 7.50 |
| DSP Large Cap Fund - Direct Plan - Growth | 5 | 6933.59 | 2.36 | 4.25 | 4.32 | 9.48 | 18.65 |
| DSP Arbitrage fund - Direct Plan - Growth | 3 | 6447.92 | 0.52 | 1.47 | 3.20 | 6.87 | 7.71 |